|
Sales Training America to Engineer Win-Win Negotiations Training for Emergent BiosolutionsEmergent BioSolutions Inc., a global biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies, has contracted with Sales Training America to provide Win-Win Negotiations training for their managers. Emergent was seeking a training partner to provide negotiations training, and a representative who attended one of STA's open enrollment seminars was quick to move forward in planning a private session for his group. An STA Win-Win Negotiations Senior Level Training Instructor will travel to Michigan State University to lead the training workshop. Participants in this highly interactive negotiations training class will discover the importance of planning for negotiations in advance, charting concession strategies and setting expectations, helping them strategize when to give ground and when to hold out. Negotiations training workshop attendees will also learn how to recognize and handle a number of negotiation styles, strategies and tactics, allowing them to stay one step ahead throughout any negotiation process. About Sales Training America Sales Training America is headquartered in Houston, Texas and has employees and certified partners in more than 20 cities across the US. Internationally, STA’s footprint includes the United Kingdom, Dubai, Singapore, Argentina, Brazil and Russia. As one of America’s fastest-growing corporate training companies, Sales Training America has helped over a million professionals reach maximum performance for over 30 years. Globally recognized companies and government agencies, including ExxonMobil, General Electric and Bank of America depend on Sales Training America to equip their employees with skills to increase market share and produce immediate results. STA provides customized, targeted, practice-driven performance improvement solutions that produce rapid, measurable results. Sales Training America’ solutions have been utilized and delivered worldwide, throughout Europe, South America, North America, the Middle East, and Asia Pacific. About Emergent Biosolutions Emergent BioSolutions Inc. is a global biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the body's immune system to prevent or treat disease. Emergent's marketed and investigational products target infectious diseases, oncology, and autoimmune disorders. BioThrax is the only FDA-licensed vaccine available for pre-exposure protection against anthrax infection. According to the Centers for Disease Control and Prevention (CDC), weaponized anthrax is one of the greatest possible threats to the public. BioThrax is for the active immunization of adults at high risk of exposure to anthrax. Emergent BioSolutions protects and enhances life by developing and manufacturing vaccines and therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. Emergent's marketed and investigational products target infectious diseases, oncology and autoimmune disorders. |
||||||
|
|||||||